Ellis Investment Partners’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,780
Closed -$42K 834
2021
Q4
$42K Buy
1,780
+25
+1% +$535 0.01% 446
2021
Q3
$35K Buy
1,755
+24
+1% +$492 0.01% 439
2021
Q2
$34K Sell
1,731
-42,224
-96% -$903K 0.01% 451
2021
Q1
$935K Buy
43,955
+553
+1% +$11.9K 0.26% 76
2020
Q4
$946K Buy
43,402
+615
+1% +$12K 0.29% 66
2020
Q3
$754K Buy
42,787
+534
+1% +$9.94K 0.26% 71
2020
Q2
$816K Buy
42,253
+733
+2% +$13K 0.31% 60
2020
Q1
$631K Sell
41,520
-285
-0.7% -$5.96K 0.3% 63
2019
Q4
$869K Buy
41,805
+541
+1% +$11K 0.29% 66
2019
Q3
$796K Buy
41,264
+281
+0.7% +$5.16K 0.29% 68
2019
Q2
$715K Sell
40,983
-250
-0.6% -$4.5K 0.27% 76
2019
Q1
$772K Buy
41,233
+519
+1% +$9.25K 0.31% 71
2018
Q4
$654K Buy
+40,714
New +$644K 0.3% 74

Other funds holding MPT

Ellis Investment Partners's MPT Position: Q1 2022 in Review

Ellis Investment Partners sold out of Medical Properties Trust (MPT) in Q1 2022, closing a stake of 1,780 shares — an estimated $42K sold.

Ellis Investment Partners first reported a position in MPT in Q4 2018 and held it in 13 quarters. The position peaked at $946K in Q4 2020. 605 funds tracked by Wall St. Rank hold MPT as of Q1 2022.

  • Ellis Investment Partners reported no remaining Medical Properties Trust position as of Q1 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 1,780 Medical Properties Trust shares in Q1 2022, an estimated $42K.
  • Ellis Investment Partners first reported a position in Medical Properties Trust in Q4 2018 and held it in 13 quarters.
  • Ellis Investment Partners's Medical Properties Trust position peaked at $946K in Q4 2020.
  • 605 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2022.

Based on Ellis Investment Partners's 13F filing for Q1 2022, filed 3 May 2022.